Evidence map›Paper›PMID 41991340›Full record

Observational studyJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Circulating Tumor DNA Genomic Profiling in

Masaki Shiota, Maki Fujiwara, Takayuki Sumiyoshi, Hideki Enokida, Tomomi Kamba, Tsukasa Igawa, Naoya Masumori, Hirotsugu Uemura, Toshiyuki Kamoto, Katsuyoshi Higashijima and 8 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Masaki ShiotaDepartment of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; shiota.masaki.101@m.kyushu-u.ac.jp.
Maki FujiwaraDepartment of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takayuki SumiyoshiDepartment of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hideki EnokidaDepartment of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Tomomi KambaDepartment of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Tsukasa IgawaDepartment of Urology, School of Medicine, Kurume University, Kurume, Japan.
Naoya MasumoriDepartment of Urology, School of Medicine, Sapporo Medical University, Sapporo, Japan.
Hirotsugu UemuraDepartment of Urology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan.
Toshiyuki KamotoDepartment of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Katsuyoshi HigashijimaDepartment of Urology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kensuke MitsunariDepartment of Urology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
Hiroji UemuraDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Takashi KobayashiDepartment of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shusuke AkamatsuDepartment of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Shoji TokunagaClinical Therapeutic Trial Center, Ehime University Hospital, Japan; and.
Takuro IsodaDepartment of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kousei IshigamiDepartment of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masatoshi EtoDepartment of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor DNA (ctDNA) testing has emerged as a cancer precision medicine approach. We investigated the genomic landscape and clinical utility of ctDNA in patients receiving

Indexed as

Circulating Tumor DNAGenomicsProstatic Neoplasms, Castration-ResistantRadiumAgedAged, 80 and overBone NeoplasmsHumansMaleMiddle AgedNeoplasm MetastasisProspective StudiesRadioisotopesCirculating Tumor DNARadioisotopesRadiumRadium-223radium Ra 223 dichloride223Racirculating tumor DNActDNA fractiongenomic profileliquid biopsy

Identifiers

PMID41991340
PMCPMC13321932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.